<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xiao YY</submitter><funding>Guangzhou Medical University</funding><funding>Guangdong Provincial Drug Administration Science and Technology Innovation Project - Key Technology Research on Chest Disease Prevention and Treatment Drug Research and Clinical Evaluation</funding><funding>China Postdoctoral Science Foundation</funding><funding>National Natural Science Foundation of China</funding><funding>Natural Science Foundation of Guangdong Province</funding><funding>National Key Research and Development Program of China</funding><pagination>e13593</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11056695</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>57(5)</volume><pubmed_abstract>Ischemic heart disease, especially myocardial infarction (MI), is one of the leading causes of death worldwide, and desperately needs effective treatments, such as cell therapy. Cardiopulmonary progenitors (CPPs) are stem cells for both heart and lung, but their repairing role in damaged heart is still unknown. Here, we obtained CPPs from E9.5 mouse embryos, maintained their stemness while expanding, and identified their characteristics by scRNA-seq, flow cytometry, quantitative reverse transcription-polymerase chain reaction, and differentiation assays. Moreover, we employed mouse MI model to investigate whether CPPs could repair the injured heart. Our data identified that CPPs exhibit hybrid fibroblastic, endothelial, and mesenchymal state, and they could differentiate into cell lineages</pubmed_abstract><journal>Cell proliferation</journal><pubmed_title>Cardiopulmonary progenitors facilitate cardiac repair via exosomal transfer of miR-27b-3p targeting the SIK1-CREB1 axis.</pubmed_title><pmcid>PMC11056695</pmcid><funding_grant_id>2022M710890</funding_grant_id><funding_grant_id>2019A1515011300</funding_grant_id><funding_grant_id>2022ZDZ10</funding_grant_id><funding_grant_id>06-410-2107211</funding_grant_id><funding_grant_id>06‐410‐2107211</funding_grant_id><funding_grant_id>81900284</funding_grant_id><funding_grant_id>2022YFE0209700</funding_grant_id><pubmed_authors>Huang LJ</pubmed_authors><pubmed_authors>Xia LX</pubmed_authors><pubmed_authors>Zhao LX</pubmed_authors><pubmed_authors>Yu PJ</pubmed_authors><pubmed_authors>Jiang XY</pubmed_authors><pubmed_authors>Li KX</pubmed_authors><pubmed_authors>Jiang WJ</pubmed_authors><pubmed_authors>Chen ZS</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Qin JF</pubmed_authors><pubmed_authors>Xiao YY</pubmed_authors><pubmed_authors>Wei L</pubmed_authors><pubmed_authors>Yu XY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cardiopulmonary progenitors facilitate cardiac repair via exosomal transfer of miR-27b-3p targeting the SIK1-CREB1 axis.</name><description>Ischemic heart disease, especially myocardial infarction (MI), is one of the leading causes of death worldwide, and desperately needs effective treatments, such as cell therapy. Cardiopulmonary progenitors (CPPs) are stem cells for both heart and lung, but their repairing role in damaged heart is still unknown. Here, we obtained CPPs from E9.5 mouse embryos, maintained their stemness while expanding, and identified their characteristics by scRNA-seq, flow cytometry, quantitative reverse transcription-polymerase chain reaction, and differentiation assays. Moreover, we employed mouse MI model to investigate whether CPPs could repair the injured heart. Our data identified that CPPs exhibit hybrid fibroblastic, endothelial, and mesenchymal state, and they could differentiate into cell lineages</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-05-29T09:44:24.264Z</modification><creation>2025-07-27T03:11:07.032Z</creation></dates><accession>S-EPMC11056695</accession><cross_references><pubmed>38185757</pubmed><doi>10.1111/cpr.13593</doi></cross_references></HashMap>